Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
Super funds back COVID-19 preventative drug
Four major superannuation funds are backing a biotech company that is developing a preventative nasal spray that claims to prevent COVID-19 and the common cold.

LoginGo Premium

Read more: Ena RespiratoryChristophe DemaisonAustralianSuperBrandon CapitalCSLHESTAHostplusStatewide Super
Link to something Kc6Wd9OY